<i>APOE</i>: The New Frontier in the Development of a Therapeutic Target towards Precision Medicine in Late-Onset Alzheimer’s

by Anna Yang, Boris Kantor, Ornit Chiba-Falek
Published 2021-01-01

Google App Engine Technology to Build Life Situations Viewing System Reminiscence Therapy in Dementia Research

by Chen-Yu Hsu, 許宸毓

The Alzheimer’s Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer’s disease

by Jessica B. Langbaum, Noel N. Ellison, Angelika Caputo, Ronald G. Thomas, Carolyn Langlois, Marie-Emmanuelle Riviere, Ana Graf, Cristina Lopez Lopez, Eric M. Reiman, Pierre N. Tariot, Suzanne B. Hendrix
Published 2020-05-01

N-truncated Aβ4–x peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models

by Oliver Wirths, Susanne Walter, Inga Kraus, Hans W. Klafki, Martina Stazi, Timo J. Oberstein, Jorge Ghiso, Jens Wiltfang, Thomas A. Bayer, Sascha Weggen
Published 2017-10-01

Atrial Fibrillation and Risk of Dementia: Epidemiology, Mechanisms, and Effect of Anticoagulation

by Rose Mary Ferreira Lisboa Da Silva, Cláudia Madeira Miranda, Tong Liu, Gary Tse, Leonardo Roever
Published 2019-01-01

Langage et maladie d'Alzheimer : analyse multidimensionnelle d'un discours pathologique

by Lee, Hyeran
Published 2012

Synapsin-caveolin-1 gene therapy preserves neuronal and synaptic morphology and prevents neurodegeneration in a mouse model of AD

by Shanshan Wang, Joseph S. Leem, Sonia Podvin, Vivian Hook, Natalia Kleschevnikov, Paul Savchenko, Mehul Dhanani, Kimberly Zhou, Isabella C. Kelly, Tong Zhang, Atsushi Miyanohara, Phuong Nguyen, Alexander Kleschevnikov, Steve L. Wagner, John Q. Trojanowski, David M. Roth, Hemal H. Patel, Piyush M. Patel, Brian P. Head
Published 2021-06-01

Saporin from <i>Saponaria officinalis</i> as a Tool for Experimental Research, Modeling, and Therapy in Neuroscience

by Alexey P. Bolshakov, Mikhail Yu. Stepanichev, Yulia V. Dobryakova, Yulia S. Spivak, Vladimir A. Markevich
Published 2020-08-01

Therapeutic Actions of the Thiazolidinediones in Alzheimer’s Disease

by María José Pérez, Rodrigo A. Quintanilla
Published 2015-01-01

Listening to the voices of dementia:the therapist's teaching-learning process through co-construction of narrative and the triadic relationship with Alzheimer’s disease sufferers

by Watanabe, R. (Ryoko)
Published 2016

Targeting neuroinflammation in Alzheimer&rsquo;s disease

by Bronzuoli MR, Iacomino A, Steardo L, Scuderi C
Published 2016-11-01

Efficacy and safety of pharmacotherapy for Alzheimer’s disease and for behavioural...

by M. Seibert, V. Mühlbauer, J. Holbrook, S. Voigt-Radloff, S. Brefka, D. Dallmeier, M. Denkinger, C. Schönfeldt-Lecuona, S. Klöppel, C. A. F. von Arnim
Published 2021-07-01

The “rights” of precision drug development for Alzheimer’s disease

by Jeffrey Cummings, Howard H. Feldman, Philip Scheltens
Published 2019-08-01

Reproducibility of EEG functional connectivity in Alzheimer’s disease

by Casper T. Briels, Deborah N. Schoonhoven, Cornelis J. Stam, Hanneke de Waal, Philip Scheltens, Alida A. Gouw
Published 2020-06-01

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

by Gayatri Devi, Philip Scheltens
Published 2018-12-01

Alzheimer disease pathology and the cerebrospinal fluid proteome

by Loïc Dayon, Antonio Núñez Galindo, Jérôme Wojcik, Ornella Cominetti, John Corthésy, Aikaterini Oikonomidi, Hugues Henry, Martin Kussmann, Eugenia Migliavacca, India Severin, Gene L. Bowman, Julius Popp
Published 2018-07-01

Secondary prevention of Alzheimer’s dementia: neuroimaging contributions

by Mara ten Kate, Silvia Ingala, Adam J. Schwarz, Nick C. Fox, Gaël Chételat, Bart N. M. van Berckel, Michael Ewers, Christopher Foley, Juan Domingo Gispert, Derek Hill, Michael C. Irizarry, Adriaan A. Lammertsma, José Luis Molinuevo, Craig Ritchie, Philip Scheltens, Mark E. Schmidt, Pieter Jelle Visser, Adam Waldman, Joanna Wardlaw, Sven Haller, Frederik Barkhof
Published 2018-10-01

Rho GTPases as therapeutic targets in Alzheimer’s disease

by Byron J. Aguilar, Yi Zhu, Qun Lu
Published 2017-12-01

On the path to 2025: understanding the Alzheimer’s disease continuum

by Paul S. Aisen, Jeffrey Cummings, Clifford R. Jack, John C. Morris, Reisa Sperling, Lutz Frölich, Roy W. Jones, Sherie A. Dowsett, Brandy R. Matthews, Joel Raskin, Philip Scheltens, Bruno Dubois
Published 2017-08-01

Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau...

by Anna Zettergren, Jodie Lord, Nicholas J. Ashton, Andrea L. Benedet, Thomas K. Karikari, Juan Lantero Rodriguez, the Alzheimer’s Disease Neuroimaging Initiative*, Anniina Snellman, Marc Suárez-Calvet, Petroula Proitsi, Henrik Zetterberg, Kaj Blennow
Published 2021-01-01